Allianz SE purchased a new stake in shares of MetLife, Inc. (NYSE:MET – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 108,964 shares of the financial services provider’s stock, valued at approximately $8,882,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. CX Institutional raised its stake in MetLife by 15.9% in the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock worth $5,568,000 after acquiring an additional 9,337 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of MetLife by 109.2% in the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after purchasing an additional 4,606,748 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of MetLife by 27.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock worth $1,116,000 after purchasing an additional 2,940 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in MetLife by 1.7% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock valued at $63,559,000 after buying an additional 12,723 shares during the last quarter. Finally, Kingswood Wealth Advisors LLC acquired a new position in MetLife in the 4th quarter worth approximately $259,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have commented on MET. Wells Fargo & Company lifted their price objective on shares of MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. Barclays cut their price target on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. JPMorgan Chase & Co. boosted their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Keefe, Bruyette & Woods dropped their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a report on Wednesday, February 12th. Finally, Morgan Stanley boosted their price target on MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a report on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $94.58.
MetLife Stock Performance
MET opened at $79.19 on Friday. The company has a market cap of $53.95 billion, a price-to-earnings ratio of 13.27, a PEG ratio of 0.65 and a beta of 1.04. The firm’s fifty day simple moving average is $83.29 and its two-hundred day simple moving average is $82.83. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 52-week low of $67.30 and a 52-week high of $89.05.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were issued a $0.545 dividend. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.75%. MetLife’s payout ratio is currently 36.52%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- How to Profit From Value Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
- Breakout Stocks: What They Are and How to Identify Them
- Affirm Strikes Back: Can a New Deal Mitigate the Recent Loss?
- Canada Bond Market Holiday: How to Invest and Trade
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.